BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24423239)

  • 21. High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma.
    Li H; Li X; Lin H; Gong J
    Mol Med Rep; 2020 Feb; 21(2):822-832. PubMed ID: 31974610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of transmembrane protein 2 (TMEM2), a novel hyaluronidase, predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Kudo Y; Sato N; Adachi Y; Amaike T; Koga A; Kohi S; Noguchi H; Nakayama T; Hirata K
    Pancreatology; 2020 Oct; 20(7):1479-1485. PubMed ID: 32948431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.
    You N; Li J; Gong Z; Huang X; Wang W; Wang L; Wu K; Zheng L
    Mol Carcinog; 2017 Feb; 56(2):607-624. PubMed ID: 27350032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma.
    Hang C; Gong C; Fang Y; Chen L; Zhu J
    J Mol Histol; 2021 Apr; 52(2):187-196. PubMed ID: 33394290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer.
    Bai X; Song Z; Fu Y; Yu Z; Zhao L; Zhao H; Yao W; Huang D; Mi X; Wang E; Zheng Z; Wei M
    PLoS One; 2012; 7(6):e40024. PubMed ID: 22768205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt-11 Expression Promotes Invasiveness and Correlates with Survival in Human Pancreatic Ductal Adeno Carcinoma.
    Dart DA; Arisan DE; Owen S; Hao C; Jiang WG; Uysal-Onganer P
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31718047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of angiotensin-converting enzyme 2 in pancreatic ductal adenocarcinoma is associated with tumor progression.
    Zhou L; Zhang R; Yao W; Wang J; Qian A; Qiao M; Zhang Y; Yuan Y
    Tohoku J Exp Med; 2009 Feb; 217(2):123-31. PubMed ID: 19212105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
    Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
    J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel epigenetic mechanism regulating hyaluronan production in pancreatic cancer cells.
    Kohi S; Sato N; Cheng XB; Koga A; Higure A; Hirata K
    Clin Exp Metastasis; 2016 Mar; 33(3):225-30. PubMed ID: 26589701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
    Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
    Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway.
    Chen Y; Bai X; Zhang Q; Wen L; Su W; Fu Q; Sun X; Lou Y; Yang J; Zhang J; Chen Q; Wang J; Liang T
    Cancer Lett; 2016 Sep; 380(1):98-105. PubMed ID: 27339327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
    Liu XD; Zhang ZW; Wu HW; Liang ZY
    Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.
    Robertson KD; Uzvolgyi E; Liang G; Talmadge C; Sumegi J; Gonzales FA; Jones PA
    Nucleic Acids Res; 1999 Jun; 27(11):2291-8. PubMed ID: 10325416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Weng S; Wang H; Chen W; Katz MH; Chatterjee D; Lee JE; Pisters PW; Gomez HF; Abbruzzese JL; Fleming JB; Wang H
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1336-43. PubMed ID: 22665577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294.
    Xu Y; Yao Y; Gao P; Cui Y
    Biochem Biophys Res Commun; 2019 Jan; 509(1):138-142. PubMed ID: 30591218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis.
    Zhu X; Shi C; Peng Y; Yin L; Tu M; Chen Q; Hou C; Li Q; Miao Y
    Cell Prolif; 2018 Jun; 51(3):e12428. PubMed ID: 29266545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma.
    Fan J; Yang MX; Ouyang Q; Fu D; Xu Z; Liu X; Mino-Kenudson M; Geng J; Tang F
    Hum Pathol; 2016 Sep; 55():151-8. PubMed ID: 27195906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
    Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
    Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of miR‑29b targets DNMT3b to suppress cellular apoptosis and enhance proliferation in pancreatic cancer.
    Wang LH; Huang J; Wu CR; Huang LY; Cui J; Xing ZZ; Zhao CY
    Mol Med Rep; 2018 Feb; 17(2):2113-2120. PubMed ID: 29207141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.